A UK-led study identifies immune cell clusters and their interactions with endothelial and collagen-producing cells as potential drivers of fibrosis in Crohn’s disease, highlighting a key mechanism behind scarring in the condition.

Researchers validated their findings by combining traditional pathology with single-cell transcriptomics and confirmed results through two independent approaches, strengthening the case for the identified therapeutic targets.

Experts and patient advocates welcomed the findings as offering hope for treatments that address not only inflammation but also the lasting tissue damage caused by fibrosis in Crohn’s disease.

The study leveraged archived tissue for histology alongside fresh tissue for single-cell analysis, providing two independent validation methods.

Personal perspective comes from a Crohn’s patient, Maureen Dalgleish, who donated tissue after multiple surgeries for fibrosis, underscoring the real-life impact and potential for future therapies.